Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion type Assertion NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_head.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion description "[These observations suggest that the NAT1*11 variant and the GSTM1 wild-type genotype contribute to a more favorable outcome in patients treated for neuroblastoma and are the first to demonstrate a relationship between NAT1 and GSTM1 genotypes in childhood neuroblastoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_provenance.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion evidence source_evidence_literature NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_provenance.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion SIO_000772 17700360 NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_provenance.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion wasDerivedFrom befree-2016 NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_provenance.
- NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_assertion wasGeneratedBy ECO_0000203 NP625260.RAsniDHAKBBb0LNvqFdhHJaBU-4U5lw3r1m79iEFT1myE130_provenance.